In the UK, screening is not recommended routinely, instead Public Health England runs a ‘prostate cancer risk management program’ in which patients who are concerned about prostate cancer are able to have a PSA test after a discussion with a GP on the benefits and harms of the test in order to make an informed choice [3]. The gene discussed is KLK3; the disease is Familial prostate cancer.